Secondary end-points are to assess the 30-day infectious and non-infectious morbidity , length of antibiotic treatment and hospital stay , modifications on total food intake , compliance to treatment , side-effects of immunonutrition , impact on liver regeneration and sarcopenia , and to perform a medico-economic analysis .